July 16, 2014

Beauty brand philosophy has announced the launch of the hope & grace initiative to support mental health. Through the hope & grace initiative, philosophy will dedicate 1% of all sales across all products to organizations working to empower women through the promotion, prevention and treatment of mental health.

April 9, 2014

According to new survey data recently released by the National Consumers League, one-third of adult Americans still believe that vaccines may be linked to autism in children.

March 3, 2014

Teva Pharmaceutical Industries announced the launch of Adasuve (loxapine) inhalation powder in a 10-mg dosage. The drug is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults.

February 27, 2014

A long-term study by UCLA, in collaboration with the University of Aarhus in Denmark, has raised concerns about the use of acetaminophen during pregnancy, UCLA announced earlier this week.

February 26, 2014

A study released Wednesday by Rhonda Patrick and Bruce Ames of Children's Hospital Oakland Research Institute demonstrated the impact that vitamin D may have on social behavior associated with Autism Spectrum Disorder.

January 22, 2014

Takeda Pharmaceuticals and Lundbeck announced the availability of Brintellix (vortioxetine), a once-daily oral antidepressant for treatment of major depressive disorder in adults.

December 18, 2013

A new study has found a significant increase in the number of high school students who report having abused a common prescription drug for attention deficit hyperactivity disorder, even as abuse of other prescription drugs has decreased or remained low.

December 2, 2013

The Food and Drug Administration has approved a generic version of a drug for schizophrenia and bipolar disorder made by Jubilant Life Sciences, the Indian drug maker said.

December 2, 2013

Sandoz will market an authorized generic version of an attention deficit hyperactivity disorder drug made by Shire under a contract between the two companies, Shire said Monday.

November 21, 2013

The Food and Drug Administration has declined to approve an experimental drug for schizophrenia and bipolar disorder developed by Forest Labs and Gedeon Richter, a Hungarian drug company, the two said Thursday.

November 21, 2013

Teva has introduced a generic version of a drug used to treat attention deficit hyperactivity disorder, the company said Thursday.

November 18, 2013

Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.

October 31, 2013

A personalized medicine company said a new study justifies clinical use of pharmacogenomic testing to help predict patients' response to psychiatric medications and improve treatment outcomes.

October 1, 2013

The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

August 21, 2013

Rite Aid's philanthropic arm has donated $10,000 to benefit children with autism, according to published reports.

August 1, 2013

Walgreens opened a new training facility here in partnership with Have Dreams, an advocacy group for children with autism, according to a story published Wednesday by Evanston Now.

The training involves setting up displays, working the cash register, stocking and organizing shelves and other skill sets that enable the autistic students to make a contribution to a store’s operations.

July 2, 2013

GoodNites, a Kimberly-Clark brand, is helping bed-wetting kids feel confident overnight with a new design that fits more like real underwear.

May 30, 2013

Drugs for attention deficit hyperactivity disorder don't appear to increase children's risk of abusing drugs and alcohol later in life, according to a new study.

May 21, 2013

The Ad Council and Autism Speaks have launched a series of public service announcements encouraging awareness about autism among African-American and Hispanic parents.

April 25, 2013

Actavis can launch a generic version of an attention deficit hyperactivity disorder drug made by Shire next year under an agreement between the two companies announced Thursday.

April 2, 2013

More than one-tenth of school-age children and nearly one-fifth of high school boys in the United States have received a diagnosis for attention deficit hyperactivity disorder, according to published reports.

March 1, 2013

The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.

February 11, 2013

Generic drug maker Impax Labs has settled with Shire Labs over an authorized generic version of a Shire drug for treating attention deficit hyperactivity disorder, Impax said.

January 23, 2013

The National Advertising Division on Tuesday recommended that Nature’s Answer discontinue a wide range of Internet advertising claims for “Bio-Strath,” including claims that the supplement benefits children with ADD/ADHD, pregnant women, people recovering from cancer treatments, people with dementia and people with diabetes.